Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 764
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
for
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS),
Location: Washington D.C. DC, Hershey PA, Richmond VA,
Location: Washington D.C. DC, Ann Arbor MI, Chicago IL,
Sponsor: Ultragenyx Pharmaceutical Inc
Sex: All
Age: 0+
Code: NCT03604835
Recruiting
Augmented Reality Ultrasound Guidance
for
Paracentesis
Location: Washington DC
Sponsor: Children's National Research Institute
Sex: All
Age: 18 - 70+
Code: NCT05964439
Recruiting
Ultrasound for Scoliosis Diagnostic Evaluation
for
Scoliosis Idiopathic, Scoliosis; Juvenile
Location: Washington DC
Sponsor: Children's National Research Institute
Sex: All
Age: 7 - 17
Code: NCT03222739
Recruiting
Pediatric Dose Optimization for Seizures in Emergency Medical Services
for
Seizures
Location: Washington D.C. DC, Pittsburgh PA, Buffalo NY,
Sponsor: Stanford University
Sex: All
Age: 0 - 13
Code: NCT05121324
Phase3, Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Washington D.C. DC, Durham NC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 3 - 39
Code: NCT05096481
Phase2, Recruiting
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
for
Autosomal Recessive Polycystic Kidney (ARPKD)
Location: Washington D.C. DC, Baltimore MD, Cleveland OH,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 0 - 18
Code: NCT04782258
Phase3, Recruiting
T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients